Field F J, Born E, Chen H, Murthy S, Mathur S N
Department of Internal Medicine, University of Iowa, Iowa City, USA.
J Lipid Res. 1995 Jul;36(7):1533-43.
Acylcoenzyme A:cholesterol acyltransferase (ACAT) and/or cholesteryl esters have been implicated as important factors in the normal assembly of apolipoprotein (apoB)-containing lipoproteins. The predominant substrate for ACAT is believed to originate from cholesterol contained within the plasma membrane. To investigate a possible role of intestinal plasma membrane cholesterol in triacylglycerol-rich lipoprotein synthesis and secretion, CaCo-2 cells were incubated with agents that are known to interfere with cholesterol transport from the plasma membrane to the ER. Progesterone, verapamil, and trifluoperazine significantly decreased the movement of cholesterol from plasma membrane to endoplasmic reticulum (ER) in CaCo-2 cells. Without altering the synthesis of apoB and independent of their effects on cellular cholesterol esterification, progesterone, verapamil, and trifluoperazine decreased the basolateral secretion of triacylglycerols, cholesteryl esters, and immunoreactive and newly synthesized apoB. The three agents also interfered with the esterification of cholesterol absorbed from taurocholate micelles. As progesterone, verapamil, and trifluoperazine are recognized inhibitors of p-glycoprotein, a variety of agents that have been shown to interfere with p-glycoprotein function were tested to investigate their effects on cholesterol transport and apoB secretion. All the agents significantly decreased in parallel both cholesterol transport and apoB secretion. In contrast, methotrexate, an antimetabolite that does not interact with p-glycoprotein, had no effect. Nigericin, a potassium ionophore, which causes alkalinization of intracellular vesicles, also caused a profound inhibition of cholesterol transport and apoB secretion. Preventing plasma membrane cholesterol from arriving at the ER, or inhibiting the esterification of plasma membrane cholesterol, does not alter apoB secretion. However, the results suggest a possible role for p-glycoprotein in normal cholesterol trafficking and triacylglycerol-rich lipoprotein secretion in CaCo-2 cells. It is postulated that p-glycoprotein might function to maintain the acidic environment of transport vesicles, and therefore, could play a role in the transport of lipids by the intestine.
酰基辅酶A:胆固醇酰基转移酶(ACAT)和/或胆固醇酯被认为是含载脂蛋白(apoB)脂蛋白正常组装的重要因素。ACAT的主要底物据信源自质膜内所含的胆固醇。为了研究肠质膜胆固醇在富含三酰甘油的脂蛋白合成和分泌中的可能作用,将CaCo-2细胞与已知会干扰胆固醇从质膜转运至内质网(ER)的试剂一起孵育。孕酮、维拉帕米和三氟拉嗪显著降低了CaCo-2细胞中胆固醇从质膜向内质网(ER)的转运。在不改变apoB合成且独立于其对细胞胆固醇酯化作用的情况下,孕酮、维拉帕米和三氟拉嗪降低了三酰甘油、胆固醇酯以及免疫反应性和新合成的apoB的基底外侧分泌。这三种试剂还干扰了从牛磺胆酸盐微团吸收的胆固醇的酯化。由于孕酮、维拉帕米和三氟拉嗪是公认的P-糖蛋白抑制剂,因此测试了多种已证明会干扰P-糖蛋白功能的试剂,以研究它们对胆固醇转运和apoB分泌的影响。所有试剂均同时显著降低了胆固醇转运和apoB分泌。相比之下,不与P-糖蛋白相互作用的抗代谢物甲氨蝶呤则没有影响。尼日利亚菌素是一种钾离子载体,可导致细胞内小泡碱化,它也对胆固醇转运和apoB分泌产生了显著抑制作用。阻止质膜胆固醇到达内质网或抑制质膜胆固醇的酯化,不会改变apoB分泌。然而,结果表明P-糖蛋白在CaCo-2细胞正常的胆固醇转运和富含三酰甘油的脂蛋白分泌中可能发挥作用。据推测,P-糖蛋白可能起到维持转运小泡酸性环境的作用,因此可能在肠道脂质转运中发挥作用。